News und Analysen
Pentair Provides Business Updates Related to COVID-19 Impact
Pentair plc (NYSE: PNR) today provided a business update in light of recent suspensions of operations caused by COVID-19. Previously, global demand remained healthy and Pentair was poised to
Symmetry, das LivaNova VNS Therapy-System für schwer zu behandelnde Depressionen, erhält CE-Prüfzeichen
LivaNova PLC (NASDAQ:LIVN), ein marktführendes medizintechnisches Innovationsunternehmen, gab heute bekannt, dass sein System Vagus Nerve Stimulation Therapy® (VNS Therapy) Symmetry™ die
LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval
Pentair to Present at J.P. Morgan Industrials Conference
Pentair plc (NYSE: PNR) President and Chief Executive Officer John L. Stauch will present at the J.P. Morgan Industrials Conference held in New York, NY., on Tuesday, March 10, 2020. Mr. Stauch’s
Pentair Engineer Honored by 8th Annual STEP Ahead Awards Recognizing Women for Excellence in Manufacturing
Pentair plc (NYSE: PNR), a global water treatment company, announced that the Manufacturing Institute will award Sonal Gola, Smart Products & IoT Delivery Manager at Pentair, with the Women in
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a research collaboration with Verily, an Alphabet company, to capture measures of depression
LivaNova Reports Fourth Quarter and Full-Year 2019 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2019.
For the fourth quarter of
LivaNova Receives FDA Clearance for 3T Heater-Cooler Device Modification
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for a device
Pentair Announces Quarterly Cash Dividend
Pentair plc (NYSE: PNR) announced today that it will pay a regular quarterly cash dividend of $0.19 per share on May 1, 2020 to shareholders of record at the close of business on April 17, 2020
New International Consensus Statement Proposes “Difficult-to-treat Depression” as a More Clinically Useful Definition than “Treatment-Resistant Depression”
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, commends the recent international consensus statement published in the Journal of Affective Disorders for
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2019 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2019 results on Wednesday, Feb. 26
Pentair Reports Fourth Quarter and Full Year 2019 Results
Pentair plc (NYSE: PNR) today announced fourth quarter 2019 sales of $755 million. Sales were up 2 percent compared to sales for the same period last year. Excluding currency translation
Pentair plc Announces the Resignation of CFO Mark Borin
Pentair plc (NYSE:PNR) today announced that Mark Borin has informed the Company of his intention to resign as Executive Vice President, Chief Financial Officer and Chief Accounting Officer and that
Putting Purpose Into Practice: Pentair and the Pentair Foundation Contribute Nearly $3 Million to Support Communities Around the World
Pentair plc, a global water treatment company, and the Pentair Foundation announce their twenty-first consecutive year of giving to strengthen communities around the world, increase access to
Pentair to Release Fourth Quarter and Full Year 2019 Earnings and Host Investor Conference Call on January 28
Pentair plc (NYSE:PNR) will report its fourth quarter and full year results before the opening of the New York Stock Exchange on Tuesday, January 28, 2020. The company will also hold a conference
Amarin: Vorzeitige Bescherung durch die FDA!
Am vergangenen Freitag, dem 13. Dezember, war die Aktie von Amarin (WKN: A0NBNG) in den USA den größten Teil des Tages vom Handel ausgesetzt. Grund hierfür war eine bevorstehende, Kurs bewegende
Pentair Announces Dividend Increase and Quarterly Cash Dividend
Pentair plc (NYSE: PNR) announced today that its Board of Directors has approved a 6 percent increase in the company’s regular cash dividend rate (from $0.18 per share to $0.19 per share) and that
LivaNova to Present New Data on Vagus Nerve Stimulation Therapy System at the American Epilepsy Society 2019 Annual Meeting
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present new registry data from two patient populations benefiting from Vagus Nerve
LivaNova to Restructure its Heart Valve Business Line and End Caisson Transcatheter Mitral Valve Replacement Program
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it is ending its Caisson Transcatheter Mitral Valve Replacement (TMVR) program and will
LivaNova restrukturiert sein Geschäftsgebiet Herzklappen und beendet das Programm zum Austausch von Mitralklappen mit Caisson-Transkathetern
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen der Medizintechnik und Innovation, gab heute bekannt, dass es sein Programm Caisson Transcatheter Mitral Valve Replacement (TMVR) beendet
LivaNova to Present at the Berenberg and Piper Jaffray Conferences
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Thad Huston, Chief Financial Officer, will participate in discussions at the Berenberg European Conference
Amarin: 16:0-Kantersieg beim gestrigen FDA-Meeting
Die Aktie des irisch-amerikanischen Biotechunternehmens Amarin (WKN: A0NBNG) ist schon seit einiger Zeit vom Handel ausgesetzt. Grund für diese Handelsaussetzung war das angekündigte Treffen von
Amarin: 16:0-Kantersieg bei FDA-Meeting
Die Aktie des irisch-amerikanischen Biotechunternehmens Amarin (WKN: A0NBNG) ist schon seit einiger Zeit vom Handel ausgesetzt. Grund für diese Handelsaussetzung war das angekündigte Treffen von
Pentair’s Powerful and Energy Efficient Variable Speed Pump Named “Best New Product” at International Pool | Spa | Patio Expo
Pentair, a leading water treatment company and manufacturer of pool and spa equipment, received the “Best New Product – Equipment Pad” award for the third consecutive year at the 2019 International
LivaNova Honors Epilepsy Awareness Month
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, honors National Epilepsy Awareness Month in the United States this November. The company is working to bring